Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Aressy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|December 17, 2008
Cell cycle control by the CDC25 phosphatasesBernadette Aressy, Bernard Ducommun
Current Biology : CB|September 29, 2012
DNA damage: placing BRCA1 in the proper contextBernadette Aressy, Roger A Greenberg
Molecular Cancer|February 5, 2010
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damageBéatrix Bugler, Estelle Schmitt, Bernadette Aressy, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agentsBernadette Aressy, Béatrix Bugler, Annie Valette, et al.
Molecular Cancer Therapeutics|July 5, 2006
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expressionBéatrix Bugler, Muriel Quaranta, Bernadette Aressy, et al.
Blood|February 1, 2015
MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signalingKrasimira Rozenova, Jing Jiang, Ryan Donaghy, et al.
Cell Cycle (Georgetown, Tex.)|October 9, 2010
A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stabilityBernadette Aressy, Denis Jullien, Martine Cazales, et al.
Genes & Development|September 5, 2015
MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-linksQinqin Jiang, Manikandan Paramasivam, Bernadette Aressy, et al.
Cell Reports|October 1, 2013
A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responsesHui Zheng, Vibhor Gupta, Jeffrey Patterson-Fortin, et al.
Science Translational Medicine|February 24, 2012
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functionsSzilvia Solyom, Bernadette Aressy, Katri Pylkäs, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|December 17, 2008
Cell cycle control by the CDC25 phosphatasesBernadette Aressy, Bernard Ducommun
Current Biology : CB|September 29, 2012
DNA damage: placing BRCA1 in the proper contextBernadette Aressy, Roger A Greenberg
Molecular Cancer|February 5, 2010
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damageBéatrix Bugler, Estelle Schmitt, Bernadette Aressy, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agentsBernadette Aressy, Béatrix Bugler, Annie Valette, et al.
Molecular Cancer Therapeutics|July 5, 2006
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expressionBéatrix Bugler, Muriel Quaranta, Bernadette Aressy, et al.
Blood|February 1, 2015
MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signalingKrasimira Rozenova, Jing Jiang, Ryan Donaghy, et al.
Cell Cycle (Georgetown, Tex.)|October 9, 2010
A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stabilityBernadette Aressy, Denis Jullien, Martine Cazales, et al.
Genes & Development|September 5, 2015
MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-linksQinqin Jiang, Manikandan Paramasivam, Bernadette Aressy, et al.
Cell Reports|October 1, 2013
A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responsesHui Zheng, Vibhor Gupta, Jeffrey Patterson-Fortin, et al.
Science Translational Medicine|February 24, 2012
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functionsSzilvia Solyom, Bernadette Aressy, Katri Pylkäs, et al.
Pageof 1